- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Frankfurt | 103,320 | 27.09.24 17:28:31 | +1,260 | +1,23% | 103,180 | 103,380 | 102,020 | 102,060 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 932,800 | 27.09.24 11:36:52 | -0,200 | -0,02% | 948,400 | 954,600 | 927,000 | 933,000 |
